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Abstract
OBJECTIVE—Although intrauterine nutritional stress is known to result in offspring obesity and 
metabolic phenotype, the underlying cellular/molecular mechanisms remain incompletely 
understood.We tested the hypothesis that compared to the controls, the bone marrow-derived 
mesenchymal stem cells (BMSCs) of the intrauterine growth restricted (IUGR) offspring exhibit to 
a more adipogenic phenotype.
METHODS—A well-established rat model of maternal food restriction (MFR), i.e., 50% global 
caloric restriction during the later-half of pregnancy and ad libitum diet following birth that is 
known to result in an obese offspring with a metabolic phenotype was used. BMSCs at 3 weeks of 
age were isolated, and then molecularly and functionally profiled.
RESULTS—BMSCs of the intrauterine nutritionally-restricted offspring demonstrated an 
increased proliferation and an enhanced adipogenic molecular profile at miRNA, mRNA and 
protein levels, with an overall up-regulated PPARγ (miR-30d, miR-103, PPARγ, C/EPBα, ADRP, 
LPL, SREBP1), but down-regulated Wnt (LRP5, LEF-1, β-catenin, ZNF521 and RUNX2) 
signaling profile. Following adipogenic induction, compared to the control BMSCs, the already 
up-regulated adipogenic profile of the MFR BMSCs, showed a further increased adipogenic 
response.
CONCLUSIONS—Markedly enhanced adipogenic molecular profile and increased cell 
proliferation of MFR BMSCs suggest a possible novel cellular/mechanistic link between the 
intrauterine nutritional stress and offspring metabolic phenotype including obesity, providing new 
potential predictive and therapeutic targets against these conditions in the IUGR offspring.
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INTRODUCTION
Despite intense research the underlying cellular/molecular mechanisms resulting in obesity 
and the associated metabolic phenotype remain incompletely understood. Although “caloric 
imbalance”, is an important contributor to obesity 1, it is abundantly clear that maternal 
nutrition is a major intrauterine environmental factor for the expression of the fetal genome, 
with lifelong consequences on the health of the offspring, including the development of 
obesity and metabolic syndrome 2. This phenomenon, termed “fetal programming” and the 
consequent “fetal origins of adult diseases” has been well-described in offspring following 
intrauterine growth restriction (IUGR) 3-5, but the underlying cellular/molecular link 
between the two remains unknown. Though a shift towards increased adipogenic 
programming in adipose tissue of IUGR infants has been demonstrated 6, whether this effect 
is also seen in mesenchymal stem cells (MSCs) in other locations, i.e., specifically in the 
bone marrow, is not known. If proven to be so, it would implicate a much broader bearing of 
IUGR in altering offspring cellular/molecular programming in general and setting the stage 
for obesity and metabolic syndrome rather than its effects only on the adipocyte precursors 
in the adipose tissue.
Mesenchymal stem cells including those derived from the bone marrow are pluripotent cells 
that under appropriate conditions differentiate into adipocytes, osteoblasts, myocytes, and 
other cell-types. The multi-lineage and self-renewal potential allows MSCs to play critical 
roles in cell differentiation, proliferation, homeostasis and injury repair in a variety of 
organs 7. Adipogenesis involves the differentiation of adipocytes from MSCs via a complex 
and highly controlled gene expression programming, characterized by a tight balance 
between PPARγ, the master adipogenic switch and Wnt signaling pathways 8-10. We 
hypothesized that the bone marrow-derived MSCs (BMSCs) of the IUGR offspring are 
skewed towards adipogenic differentiation, reflecting a generalized obesogenic molecular 
programming in these infants. To test this hypothesis, we used a well-established rat model 
of maternal food restriction (MFR) during pregnancy that leads to later offspring obesity and 
metabolic syndrome 11-15.
MATERIALS AND METHODS
Rat model of maternal food restriction during pregnancy
All studies were approved by the local Institutional Animal Care and Use Committee 
(IACUC) and were performed, as described previously, in accordance with the NIH and 
IACUC guidelines 11, 12, 15. First-time pregnant Sprague Dawley rat dams were purchased 
from Charles River Laboratories Inc., Hollister, CA and were housed in a facility with 
constant temperature and humidity, in a controlled 12 h light and 12 h dark cycle. At 10 days 
of gestation, the dams were provided either an ad libitum diet of standard laboratory rat 
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chow (LabDiet 5001, Brentwood, MO: protein 23%, fat 4.5%, metabolized energy 3,030 
kcal/kg) or a 50% food-restricted diet, as determined by the quantification of the normal 
intake in the ad libitum fed rats. Following delivery, both control and maternal food 
restricted pups were fed ad libitum by foster dams. To minimize bias towards selecting either 
heavier or lighter pups, on postnatal day 1 (PND1), all pups from each litter were weighed 
(MFR pups: males = 5.0 ± 0.6 g and females = 5.2 ± 0.6 g demonstrated significantly (p ≤ 
0.05) lower birth weights than that of control pups: males = 6.8 ± 0.6 g and females = 7.0 
± 0.7 g) and 6 pups (3 females and 3 males) closest to the median body weight (according to 
gender) were included in the study; the other pups were culled to keep the number of pups/
litter for experimentation purposes at 6. All studies maintained a similar number of pups per 
dam between the control and experimental groups.
Isolation of bone marrow mesenchymal stem cells (BMSCs)
At postnatal day 21 (PND21), offspring were sacrificed and marrow was extracted from 
tibias and femur and BMSCs isolated and cultured following previously described 
protocol 16, 17. Briefly, the medullary cavities of rat femurs were flushed with MEM Alpha 
(1×) + GlutaMax™−1 (Cat No.: 32561-037, Life Technologies) containing 1% penicillin-
streptomycin (anti-anti). The cells were washed once with MEM and plated at 1 × 106 cells 
per 100-mm cell culture dish (Corning, Corning, NY) in the complete media: MEM Alpha 
containing 10% fetal bovine serum (FBS) and 1% anti-anti (Gibco, Life Technologies, 
Grand Island, NY, catalog# 15240-062), and cultured at 37°C in 5% CO2. Non-adherent 
cells were removed and fresh media was added every 48 h. At confluence, the cells were 
harvested and using magnetic beads (Miltenyi Biotech, Auburn, CA), macrophages were 
depleted with anti-CD11b antibody, and other hematopoietic cells were removed using an 
anti-CD45 (both from BD Biosciences, Palo Alto, CA). Due to > 95% purity of cells at 
passage (P) 3, all experiments were conducted at P3.
Flow cytometry of BMSCs
Adherent BMSCs cells at P3 in T75 flasks were removed by trypsinization, washed with 
Ca2+, Mg2+-containing 1X PBS and blocked with 3% FBS in PBS for 30 min at 4°C. Cells 
were aliquoted (100 μl/tube) for binding and staining with 2.5 μg/mL of FITC- or Alexa 
Fluor (AF)-conjugated antibodies. Sorting was performed using a BD Biosciences FACS 
DiVa High-Speed Cell Sorter (San Diego, CA) with 350 nm, 488 nm, and 633 nm lasers. 
Anti-CD31, anti-CD73, and anti-Stro-1 were conjugated to Alexa Fluor 488, anti-CD45 to 
FITC, anti-CD90 to PE, anti-CD105 to Alexa Fluor 647, and to the appropriate isotype 
controls (all from BD Pharmingen Inc., San Diego, CA except anti-Stro-1, which was 
obtained from Invitrogen, Carlsbad, CA). Analysis was performed on a FACS Aria III BD 
(Becton Dickinson, Franklin Lakes, NJ), and the data were analyzed using FlowJo software 
(Tree Star, San Carlos, CA). Propidium iodide was used to exclude dead cells, and 
percentages of positively stained-cells were calculated by subtracting the value of isotype 
controls. Cells were negatively selected for CD31 and CD45 and positively selected for 
Stro-1, CD73 and CD105 binding. Cells were collected in 1 mL DMEM supplemented with 
10% FBS and cultured and passaged to P3 for further studies.
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Adipocyte induction
For adipogenic induction, BMSCs cultured in 6-well plates were treated with adipogenic 
induction media (MEM plus 10% FBS, supplemented with 10 μM dexamethasone, 0.5 mM 
3-isobutyl-1-methylxanthine, 10 μg/ml insulin, and 50 μM indomethacin) for 7-9 days, 
following which adipocyte induction was assessed by Oil Red O (ORO) staining. The 
control (ad libitum) and MFR BMSCs exposed to adipocyte induction media were fixed in 
4% paraformaldehyde for 15 min and washed with 1× PBS. 300 μl of ORO was added to the 
slides and kept for 30 min at RT. The slides were washed with 1× PBS and allowed to react 
with hematoxylin and then mounted with aqueous mounting medium.
Myocytes induction
Myogenic differentiation was induced by addition of 10 ng/mL transforming growth factor 
(TGF)-β, 1 μg/mL insulin, 0.55 μg/mL transferrin and 670 ng/mL selenium (Invitrogen, 
Carlsbad, CA) for 6 days, following which cells were immunostained for α-smooth muscle 
actin (SMA).
Osteogenic induction (Alizarin red s staining)
Osteogenic differentiation was accomplished by culturing cells in MEM, supplemented with 
5% FBS, 100 nM dexamethasone, 10 mM b-glycerophosphate and 50μg/mL ascorbic acid 
for 10-14 days, as described 18. Formalin-fixed cells were stained for calcium phosphate 
with alizarin red S.
Western blotting analysis
Cells from control and MFR conditions were lysed using cell lysis buffer (Pierce Protein 
Research Products, Rockford, IL, Cat. No.: 89900) containing protease inhibitors. Samples 
were homogenized, and the resulting lysates were centrifuged to obtain clear supernatant. 
Protein concentration was determined by BCA protein assay (Pierce BCA Protein Assay Kit, 
Rockford, IL, prod # 23225). Fifty microgram of protein lysate from each sample was 
resolved by SDS-PAGE gel electrophoresis and data analyzed, following our previously 
described methods 11, 19. The specific primary antibodies used included PPARγ (H-100, 
Cat. No.: sc-7196, 1:200), adipocyte differentiation-related protein (ADRP) (H-80, (Cat. 
No.: sc-32888, 1:150), CCAAT/enhancer binding protein α (C/EBPα) (14AA, Cat. No.: 
sc-61, 1:200), β-catenin (E-5, Cat. No.: sc-7963, 1:250), lymphoid enhancer-binding factor 1 
(LEF1) (H-70, Cat. No.: sc-28687, 1:250), All of the above primary antibodies were 
purchased from Santa Cruz Biotechnology, Inc, Santa Cruz, CA. Mouse stro-1 (1:500) 
(eBioscience, Cat. No.: 14-6688-80) and goat anti-Rat endoglin/CD105 antigen affinity-
purified polyclonal antibody (Novus, Cat. No.: AF6440) (1:1000) were purchased from their 
respective vendors.
RNA isolation and quantitative real-time PCR
Total RNA was isolated from cultured BMSCs using Qiagen RNAeasy plus mini kit (Qiagen 
Applied Biosystems, Foster City, CA, Cat. No.: 74134); the extracted RNA was quantitated 
by absorbance using a nanodrop spectrophotometer (Nanodrop Instruments, Wilmington, 
DE) and processed for q-RT-PCR according to our previously described methods 12, 15. All 
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PCR primers were obtained from Sigma-Aldrich (St. Louis, MO), which included 18S: 5’- 
GGACAGGATTGACAGATTGATAGC -3’ (forward) and 5’- 
GGTTATCGGAATTAACCAGACAA -3’ (reverse); ADRP: 5’- 
ATTCTGGACCGTGCCGATT -3’ (forward) and 5’- CTGCTACTGATGCCATTTTTCCT 
-3’ (reverse); SREBP1: 5’- GTGGTCTTCCAGAGGCTGAG -3’ (forward) and 5’- 
GGGTGAGAGCCTTGAGACAG -3’ (reverse); C/EBPα: 5’- 
AGTTGACCAGTGACAATGACCG -3’ (forward) and 5’- 
TCAGGCAGCTGGCGGAAGAT -3’ (reverse); PPARγ: 5’- 
CCAAGTGACTCTGCTCAAGTATGG -3’ (forward) and 5’- 
CATGAATCCTTGTCCCTCTGATATG -3’ (reverse); LPL: 5’- 
TGAAGACACAGCTGAGGACA -3’ (forward) and 5’- GATCACCACAAAGGTTTTGC 
-3’ (reverse); LRP5: 5’- TGTGAACACCGAGATCAATG -3’ (forward) and 5’- 
CCATCTAGGTTGGCACATTC -3’ (reverse); LRP6: 5’- 
CCAAGTGACTCTGCTCAAGTATGG -3’ (forward) and 5’- 
CATGAATCCTTGTCCCTCTGATATG -3’ (reverse); β-catenin: 5’- 
CCGTTCGCCTTCATTATGGA -3’ (forward) and 5’- GGGCAAGGTTTCGGATCAAT -3’ 
(reverse); GSK-3β: 5’- CAGCAGCCTTCAGCTTTTGG -3’ (forward) and 5’- 
CCGGAACATAGTCCAGCACCAG -3’ (reverse); LEF1: 5’- 
GAGCACGAACAGAGAAAGGAACA -3’ (forward) and 5’- 
TTGATAGCTGCGCTCTCCTTTA -3’ (reverse); ZNF521: 5’- 
CAACGTGTGCTCTCGAACCTT -3’ (forward) and 5’- GCCTAGGTGGGTCTGCATATG 
-3’ (reverse) and RUNX2: 5’- GCCGGGAATGATGAGAACTA -3’ (forward) and 5’- 
GGACCGTCCACTGTCACTTT -3’ (reverse). All RT-qPCRs were performed in triplicate 
on an ABI StepOnePlus System. The relative mRNA levels were calculated using the 
2−ΔΔCT method, with β-actin mRNA as a normalizer. For miRNA detection, all primers were 
designed as described previously 20.
Immunohistochemistry
Slides with BMSCs from control and experimental conditions were fixed with 4% 
paraformaldehyde and processed for immunohistochemistry for mouse α-SMA (Sigma-
Aldrich, Cat. No.: A2547, 1:100), mouse Stro-1 and Goat Anti-Rat Endoglin/CD105 
(1:100), rabbit ZNP521 (Santa Cruz, Cat. No.: sc-84808, 1:50) and mouse RUNX2 (Santa 
Cruz, Cat. No.: sc-390351, 1:50), following previously described methods 11.
Cell proliferation assay
Cell proliferation was assessed using tetrazolium dye assay following manufacturer's 
protocol [CellTiter 96® Non-Radioactive Cell Proliferation Assay (MTT) in 96-well plate 
(5×103 cells/well), Catalog # G4000, Promega, Madison, WI] and by determining thymidine 
incorporation. For thymidine incorporation assay, BMSCs were grown in MEM with 10% 
FBS in 6-well (5×104 cells/well) plates; at 80% confluence, 1μl of 3H-thymidine 
[methyl-3H] (PerkinElmer, NET027001MC) was added to each well for 24h, following 
which radioactivity in the DNA recovered from the cells was determined using a scintillation 
beta-counter. The counts were normalized per mg protein.
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Statistical analysis
Statistical analysis performed using a 2-tailed Student's t-test for comparison of the two 
groups (α = 0.05) and Bonferroni post hoc correction. Values are expressed as mean ± SEM.
RESULTS
Characterization of BMSCs and their pluripotent potential
On PND21, MFR pups demonstrated lower weights than control pups (MFR pups: males = 
47.5 ± 1.6 g and females = 46.2 ± 1.8 g vs. control pups: males = 54.5.0 ± 3.5 g and females 
= 53.2 ± 2.5 g; p < 0.05). As described, above, BMSCs were isolated and subjected to FACS 
analysis to determine specific cell surface markers. More than 97% of cells stained negative 
for CD31 and CD45; >50% stained positive for CD73 and >95% stained positive for CD90; 
only 5-7% stained positive for CD105 and Stro-1 (Figure 1A). However, Western blotting 
and immunostaining provided clear evidence for the abundant positivity for these antigens 
(Figure 1A), indicating technical reasons for the ineffectiveness of FACS analysis in 
detecting CD105 and Stro-1 by the antibodies used by us. Furthermore, using well-described 
methods 18, 21, pluripotent potential of the control BMSCs was confirmed by their induction 
to adipocytes (positive ORO staining), myocytes (positive α-SMA staining), and osteocytes 
(positive Alizarin red S staining) (Figure 1B). Taken together, these and the FACS data 
confirm the nonendothelial MSC nature of the isolated cells.
Effect of MFR on the expression of key adipogenic mRNA and protein levels by BMSCs
Compared to control BMSCs, mRNA expression of key adipogenic genes was up-regulated 
in MFR BMSCs [PPARγ (10.2-fold) and C/EBPα (1.6-fold)], which was accompanied by 
the up-regulation of their downstream target genes [ADRP (1.7-fold), sterol regulatory 
element-binding protein 1 (SREBP1) (1.4-fold), and lipoprotein lipase (LPL) (1.7-fold), 
Figure 2A). In line with these data, protein levels of PPARγ (1.3-fold), ADRP (1.6-fold), 
and C/EBPα (1.3-fold) were up-regulated in MFR BMSCs compared to control cells 
(Figure 2B).
Effect of MFR on the expression of key Wnt mRNA and protein levels in BMSCs
Next, we determined the effect of MFR on several key intermediates of Wnt signaling, 
which is known to be antagonistic to the adipogenic program 22-24; most of the examined 
intermediates were down-regulated [LRP5 (0.75-fold), β-catenin (0.78-fold), GSK-3β (0.95-
fold) and LEF1 (0.89-fold)], though this did not reach statistical significance for GSK-3β 
and LEF-1]; in contrast LRP6 (1.35-fold) was significantly up-regulated (Figure 3A). In line 
with the mRNA data indicating the down-regulation of Wnt signaling, the protein levels of 
β-catenin and LEF1 levels were significantly reduced (0.56-fold and 0.48-fold, respectively) 
in MFR offspring BMSCs compared to controls (Figure 3B). We next examined the protein 
levels of ZFP521 25 and RUNX2 26-28, both known strong repressors of adipogenesis. By 
immunostaining, both ZFP521 and RUNX2 had weaker staining in BMSCs derived from the 
MFR group compared to the control group. Consistent with this, mRNA expression of both 
ZFP521 and RUNX2 was reduced in the MFR group, supporting overall enhanced 
adipogenesis and suppressed myogenesis in MFR BMSCs (Figure 3C).
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Effect of MFR on BMSC Proliferation
Since, in addition to adipocyte differentiation and hypertrophy, increase in cell number is a 
key component in the pathogenesis of obesity, we next determined the effect of MFR on 
BMSC proliferation. Compared with control BMSCs, MFR BMSCs demonstrated 
significantly increased cell proliferation, as determined by 3H-thymidine incorporation, 
which increased by 38% and MTT assay, which indicated a 29% increase (Figure 4).
Effect of MFR on the adipogenic differentiation potential of BMSCs
After establishing that the BMSCs of the MFR offspring demonstrate enhanced adipogenic 
programming (up-regulation of the adipogenic genes and down-regulation of the Wnt 
signaling genes) under basal conditions, we next examined their further adipogenic potential 
with appropriate adipogenic stimuli under in vitro conditions. On treatment with adipogenic 
induction media, compared with no induction condition, MFR BMSCs showed a 5-fold 
increase in adipogenic potential, as determined by the ratio of the number of differentiated 
adipocytes (positive ORO staining)/total cell number per mm2 (Figure 5A).
Next, by q-RT-PCR, the expression of key adipogenic markers was determined. Although, at 
baseline compared to the controls, the mRNA levels of key adipogenic markers were already 
significantly higher, as shown in Figure 2A, following adipogenic induction, the levels of 
PPARγ and the related adipogenic genes, LPL and ADRP showed even further significant 
increases in the MFR group; PPARγ expression increased by 29-fold, LPL by 2-fold, and 
ADRP by 267-fold; in contrast, the RUNX2 mRNA expression decreased 4-fold in MFR 
BMSCs vs. controls (Figure 5B).
Expression of key adipogenic microRNAs in BMSCs
Since miRNAs play a central role in adipocyte differentiation 29, several selected key 
adipogenic miRNAs were examined by qRT-PCR. As shown in Figure 6, in general, the 
expression of a number of miRNAs promoting adipogenesis was increased in the MFR 
BMSCs; in particular, miR-30d, which suppresses RUNX2 and is known to be a key player 
in determining mesenchymal cell lineage, increased 33-fold; let-7a and miR103, two other 
important regulator of adipogenesis, increased 2.2-fold and 4.6-fold, respectively. However, 
the increases in miR-27 and miR-130, which are also known to target PPARγ, did not reach 
statistical significance (Figure 6), indicating the activation of only selective adipogenic 
pathways in IUGR following MFR.
DISCUSSION
Characterization of BMSCs by cell surface marker staining (negative staining for CD31 and 
CD45, but positive staining for CD73, CD90, CD105, and Stro-1) and by demonstration of 
their pluripotent potential (induction to adipocytes, myocytes and osteocytes) established 
their non-hematopoietic MSC nature. The up-regulation of adipogenic markers at both 
mRNA (PPARγ, C/EBPα, ADRP, SREBP1, and LPL) and protein (PPARγ, C/EBPα, and 
ADRP) levels pointed to an enhanced adipogenic differentiation of the MFR BMSCs even 
under basal conditions. Their enhanced adipogenic potential was further confirmed by 
exposing to adipogenic induction media. Furthermore, in contrast to the up-regulation of 
Gong et al. Page 7
Int J Obes (Lond). Author manuscript; available in PMC 2017 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
adipogenesis programming, Wnt signaling genes, at both mRNA (LRP5 and β-catenin) and 
protein (β-catenin and LEF1) levels were down-regulated in the MFR BMSCs compared to 
controls. In addition, in the MFR BMSCs, both ZFP521 and RUNX2 (negative regulators of 
adipogenesis) were down-regulated. In line with these data, miRNA profile of BMSCs also 
showed significant changes in expression profile favoring adipogenesis. A 33-fold increase 
in adipogenic miR-30d, 4.6–fold increase in miR-103, and 2.2-fold increase in let-7a, 
suppressed myogenic RUNX2, which targets PPARγ, indicated up-regulated adiopogenic 
transcription programming of the MFR BMCSs. These data support the notion that BMSCs 
of the MFR offspring demonstrate suppressed Wnt signaling, favoring adipogenesis, 
providing a novel mechanistic explanation for the predisposition to obesity and metabolic 
phenotype seen in IUGR infants. Thus our both in vitro and in vivo data strongly suggest 
that MFR offspring BMSCs are capable of readily differentiating to adipocytes under 
suitable condition, via up-regulation of the adiopogenic, but suppression of the myogenic 
genes, supporting our hypothesis that MFR enhances adipogenesis of BMSCs, likely 
contributing to offspring obesity and the associated metabolic phenotype.
Though extensively researched, the molecular mechanisms leading to obesity and metabolic 
phenotype remain poorly understood. It is conceivable that an individual's obesogenic 
molecular profile plays an important contributory role. For example, in addition to altered 
glucocorticoid signaling and chromatin remodeling, IUGR fetuses have been shown to 
display enhanced adipogenic programming of adipocytes, all of which presumably 
contribute to an increased risk for obesity and metabolic syndrome 30, 31. This is in line with 
the concept of “fetal origins of later life diseases”, i.e., a stimulus occurring at a critical 
period during development has a long lasting effect on individual's health. Of note both 
excessive and low birth weights are associated with later obesity and metabolic syndrome, 
leading to an apparent paradox for predisposition to these conditions at both ends of the birth 
weight spectrum. For the present work, we rationalized that determining the molecular 
programming of BMSCs in IUGR infants, a group that is known to be at a greater risk of 
childhood obesity and metabolic syndrome, can provide fundamental insights to the 
mechanisms underlying these conditions.
Our central premise was that the intrauterine nutritional stress leads to persistent changes in 
cellular and gene expression in cells critical for determining obesogenic and metabolic 
phenotype seen in affected infants. Mechanistic studies on alterations in the molecular 
programming of adipocytes in IUGR offspring are limited. Enhanced adipogenic 
programming of the adipocytic precursors in adipose tissue following exposures to both 
over- and under-nutrition during development has been reported 32, 33; however, similar 
effects in BMSCs have not been previously described. Though it is now clear that following 
developmental nutritional restriction, both non-marrow and marrow adipocytic precursors 
are more robustly programmed towards an adipogenic phenotype, the significance of this 
finding remains somewhat unclear. On the one hand, in line with our hypothesis, it might 
represent an obesogenic state, while on the other hand, by conferring increased 
expandability of adipose storage sites in the face of excess dietary intake, it might represent 
a protective adaptation 34, 35. The former is likely to a more plausible explanation since the 
rat model of MFR during pregnancy used by us is well documented to be associated with 
offspring obesity and metabolic syndrome 13-15.
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Potential limitations of our study need to be noted. The nutrient challenge used by us is only 
one of the several potential factors that could result in IUGR; therefore, our data might not 
be applicable to IUGR that is not due to nutrient insufficiency. In fact, even nutrient 
insufficiency in an IUGR setting could result under a variety of circumstances, e.g., 
insufficiency of a specific dietary nutrient such as protein rather than the global caloric 
restriction, as used in the study, limiting the generalizability of our findings to all IUGR 
infants. In rat models of IUGR, following either maternal protein restriction or utero 
placental insufficiency, increased visceral adiposity and expression of adipogenic genes in 
visceral adipose tissue have been demonstrated 32, 33. A previous study utilizing protein 
deficiency during pregnancy in a rat model found delayed skeletal maturity profile of 
MSCs 36, perhaps in line with the suppressed Wnt signaling found in our study. 
Furthermore, response of BMSCs to nutrient stress might be different compared to stem 
cells from other sites. For example, adult stem cells respond to increased levels of free fatty 
acids in a site-specific manner 37.
Our data showing an enhanced adiopogenic, but suppressed Wnt signaling in BMSCs lends 
credence to a generalized altered differentiation programming in IUGR infants. However, 
since we did not analyze BMSCs immediately after birth, i.e., on PND1, it is possible that 
molecular programming at that stage might have be different from the one detected on 
PND21. Moreover, since postnatal diet is a strong determinant of offspring obesity, the 
molecular and functional profiles of BMSCs might have been different if a different 
postnatal feeding regimen had been used. This is particularly relevant since the rapidity of 
postnatal catch-up growth markedly increases the risk of developing adult obesity and 
metabolic syndrome 38. Our study suggests that in addition to a number of previously 
identified hormonal and molecular factors, including transcription factors, miRNAs, and 
epigenetic mechanisms that determine catch-up growth, an altered BMSC programming 
might be an additional contributing factor to this risk. Though all of the above-enumerated 
considerations require further explorations, our study provides novel data, suggesting a 
generalized adipogenic profile of MSCs in the setting of intrauterine nutrition restriction, 
which is likely to be highly relevant not only to the development of obesity, but also to the 
mechanisms underlying the associated metabolic phenotype and altered injury-repair seen in 
the affected offspring.
CONCLUSION
In summary, BMSCs isolated from rat offspring subjected to global nutritional restriction 
during the later-half of pregnancy showed markedly enhanced adipogenic, but suppressed 
Wnt signaling profile, along with an increase in cell proliferation. Taken together, this 
molecular and functional profile of MFR BMSCs suggests a new possible cellular/
mechanistic link between the intrauterine nutritional stress and the later offspring obesity 
and metabolic syndrome, providing novel potential predictive and therapeutic targets against 
these conditions in the IUGR offspring.
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Figure 1. 
Characterization of bone marrow-derived mesenchymal stem cells (BMSCs).
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Figure 2. 
Effect of maternal food restriction (MFR) on the expression of key adipogenic mRNAs in 
bone marrow-derived mesenchymal stem cells (BMSCs) of the resultant offspring. (A) By 
qRT-PCR, PPARγ and C/EBPα, and their downstream target genes ADRP, SREBP1, and 
LPL mRNA were up-regulated in MFR BMSCs compared to control cells. (B) Levels of 
adipogenic protein in BMSCs of the MFR offspring. By Western blot analysis, the protein 
levels of PPARγ, ADRP, and C/EBPα were up-regulated in MFR BMSCs compared to 
control cells (N=3, * p <.05, ***p<0.01 vs control).
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Figure 3. 
Effect of maternal food restriction (MFR) on the expression of key adipogenic mRNAs in 
bone marrow-derived mesenchymal stem cells (BMSCs) of the resultant offspring. (A) The 
mRNA levels of LRP5, β-catenin, GSK3β and LEF1 showed downward trend, though it 
didn't reach statistical significance for GSK3β and LEF-1; in contrast the mRNA levels of 
LRP6 were significantly upregulated. (B) Levels of key Wnt proteins in BMSCs of the MFR 
offspring. The protein levels of β-catenin and LEF1 levels were down-regulated in MFR 
BMSCs compared to controls (N=3, *p<0.05 vs. control). (C) Expression of ZFP521 and 
RUNX2 proteins and mRNAs in bone marrow-derived mesenchymal stem cells (BMSCs) of 
the maternal food restricted (MFR) offspring. White arrows indicate the specific signals. 
ZFP521 staining was strong, whereas, RUNX2 staining was weaker in BMSCs derived from 
the MFR group compared to the control group. Consistently, mRNA expression of ZEP521 
and RUNX2 show significantly reduction in BMSCs derived from the MFR group compared 
to the control group. (N=3, *p<0.05, ***p<0.01 vs. control).
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Figure 4. 
Effect of maternal food restriction (MFR) on cell proliferation in bone marrow-derived 
mesenchymal stem cells (BMSCs) of the resultant offspring. Compared with control 
BMSCs, MFR BMSCs demonstrated significantly increased cell proliferation, as determined 
by 3H- thymidine incorporation (A) and MTT assays (B) (N=5, *p<0.05 vs. control).
Gong et al. Page 16
Int J Obes (Lond). Author manuscript; available in PMC 2017 March 07.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Figure 5. 
Effect of maternal food restriction (MFR) on the adipogenic differentiation potential of bone 
marrow-derived mesenchymal stem cells (BMSCs). (A) Compared with the control BMSCs, 
MFR BMSCs showed 5-fold increase in adipogenic potential, as determined by the ratio of 
the number of differentiated adipocytes (positive ORO staining)/total cell number per mm2. 
(B) Although at baseline compared to the controls, the mRNA levels of key adipogenic 
markers were already higher, following adipogenic induction, the levels of adipogenic genes 
PPARγ (29-fold), LPL (36-fold) and ADRP (267-fold) increased significantly in the MFR 
group vs. the control group, whereas, in contrast, RUNX2 mRNA expression was 4-fold 
lower in MFR BMSCs compared to controls (N=3, *p<0.05, ***p<0.01 vs. control).
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Figure 6. 
Effect of maternal food restriction (MFR) on the expression of key adipogenic microRNAs 
in bone marrow-derived mesenchymal stem cells (BMSCs) of the resultant offspring. The 
expression of adipogenic miRNAs, let-7a (2.2-fold), miR-103 (4.6-fold), and miR-30d (33-
fold), was increased in the MFR BMSCs; however, the increases in miR-27 and miR-130, 
which are also known to be adipogenic did not reach statistical significance (N=3, *p<0.05, 
***p<0.01 vs. control).
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